Viking Therapeutics, Inc. (VKTX)
31.93
-1.41
(-4.23%)
USD |
NASDAQ |
Mar 03, 16:00
31.90
-0.03
(-0.09%)
After-Hours: 20:00
Viking Therapeutics Total Assets (Quarterly) : 715.73M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 112.48B |
| Pfizer Inc. | 208.16B |
| Amgen, Inc. | 90.59B |
| Hims & Hers Health, Inc. | 2.155B |
| Altimmune, Inc. | 218.45M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 76.67M |
| Shareholders Equity (Quarterly) | 639.06M |
| Debt to Equity Ratio | 0.0002 |
| Current Ratio | 9.334 |
| Net Debt Paydown Yield | 0.01% |